As of 2024-12-14, the EV/EBITDA ratio of Bionano Genomics Inc (BNGO) is -0.21. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Bionano's latest enterprise value is 19.49 mil USD. Bionano's TTM EBITDA according to its financial statements is -91.29 mil USD. Dividing these 2 quantities gives us the above Bionano EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 20.5x | 20.2x |
| Forward P/E multiples | 19.1x - 23.9x | 22.0x |
| Fair Price | (17.01) - (18.27) | (18.84) |
| Upside | -7191.3% - -7713.7% | -7952.5% |
| Date | EV/EBITDA |
| 2024-11-25 | -0.23 |
| 2024-11-22 | -0.20 |
| 2024-11-21 | -0.19 |
| 2024-11-20 | -0.18 |
| 2024-11-19 | -0.20 |
| 2024-11-18 | -0.20 |
| 2024-11-15 | -0.22 |
| 2024-11-14 | -0.23 |
| 2024-11-13 | -0.25 |
| 2024-11-12 | -0.24 |
| 2024-11-11 | -0.26 |
| 2024-11-08 | -0.26 |
| 2024-11-07 | -0.27 |
| 2024-11-06 | -0.28 |
| 2024-11-05 | -0.28 |
| 2024-11-04 | -0.26 |
| 2024-11-01 | -0.26 |
| 2024-10-31 | -0.27 |
| 2024-10-30 | -0.32 |
| 2024-10-29 | -0.30 |
| 2024-10-28 | -0.29 |
| 2024-10-25 | -0.29 |
| 2024-10-24 | -0.28 |
| 2024-10-23 | -0.27 |
| 2024-10-22 | -0.29 |
| 2024-10-21 | -0.30 |
| 2024-10-18 | -0.32 |
| 2024-10-17 | -0.31 |
| 2024-10-16 | -0.32 |
| 2024-10-15 | -0.31 |
| 2024-10-14 | -0.34 |
| 2024-10-11 | -0.36 |
| 2024-10-10 | -0.36 |
| 2024-10-09 | -0.42 |
| 2024-10-08 | -0.42 |
| 2024-10-07 | -0.43 |
| 2024-10-04 | -0.46 |
| 2024-10-03 | -0.44 |
| 2024-10-02 | -0.43 |
| 2024-10-01 | -0.42 |
| 2024-09-30 | -0.45 |
| 2024-09-27 | -0.46 |
| 2024-09-26 | -0.44 |
| 2024-09-25 | -0.40 |
| 2024-09-24 | -0.41 |
| 2024-09-23 | -0.39 |
| 2024-09-20 | -0.40 |
| 2024-09-19 | -0.41 |
| 2024-09-18 | -0.39 |
| 2024-09-17 | -0.41 |